EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Insurance Network Status and 1‐Year Health Care Utilization and Outpatient Costs Among Commercially Insured Patients With Newly Diagnosed and Non‐Definitively Treated Prostate Cancer, 2010–2021

Aurora J Grutman iD, Mark N Alshak, Michelle I Higgins, Christian P Pavlovich, Derek K Ng iD

Cancer Medicine · 2026-05 · 15 (5)

DOI: 10.1002/cam4.71983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 20.05.2026. Verfasst von Aurora J Grutman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Patient Acceptance of Health Care, Insurance, Health, Health Care Costs. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cancer care in the U.S. exceeds $200B, with patients paying over $16B out‐of‐pocket. We examined whether insurance network status (in‐network [IN] vs. out‐of‐network [OON]) at prostate cancer diagnosis was associated with subsequent OON care use and patient spending within 1 year of diagnosis.

Methods

Using the MarketScan database (2010–2021), we identified patients aged 40–64 with a new outpatient prostate cancer diagnosis. Patients who received definitive local treatment (radical prostatectomy or radiotherapy) were excluded. The exposure was network status at diagnosis. Outcomes were the proportion of OON claims and patient spending for prostate cancer‐related care and/or non‐definitive treatments during 1 year of follow‐up. Results were stratified by insurance type.

Results

Among 67,271 patients, 5% were diagnosed OON. Compared with IN diagnosis, OON diagnosis was associated with greater OON follow‐up claims (aIRR 29.0, 95% CI 25.0, 33.5), lower odds of prostate cancer‐related spending (aOR 0.55, 95% CI 0.49, 0.61), and lower outpatient costs (% difference = −8.6, 95% CI −13.4, −3.6). In stratified analyses, patients with HMO (aOR 0.54, 95% CI 0.44, 0.67) and PPO (aOR 0.47, 95% CI 0.41, 0.54) plans had lower odds of any spending. Patients with HMO (% difference = −22.3, 95% CI −30.9, −12.5) and CDHP (% difference = −26.5, 95% CI −43.6, −4.3) plans had lower costs.

Conclusions

OON diagnosis was associated with continued OON care. Some patients diagnosed OON had lower liability, likely reflecting differences in plan design and adjudicated claims. Claims‐based estimates may underestimate the financial impact of OON non‐definitive prostate cancer care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsPatient Acceptance of Health CareInsurance, HealthHealth Care CostsInsurance CoverageAmbulatory CareHumansMaleMiddle AgedAdultHealth ExpendituresUnited States

Stichwörter der Autor:innen

health care costsinsuranceprostate cancer

Autor:innen und Institutionen

  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Aurora J Grutman, Derek K Ng

Förderung

  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Grutman, A. J., Alshak, M. N., Higgins, M. I., Pavlovich, C. P., & Ng, D. K. (2026). Insurance Network Status and 1‐Year Health Care Utilization and Outpatient Costs Among Commercially Insured Patients With Newly Diagnosed and Non‐Definitively Treated Prostate Cancer, 2010–2021. Cancer Medicine, 15(5). https://doi.org/10.1002/cam4.71983

Vancouver

Grutman AJ, Alshak MN, Higgins MI, Pavlovich CP, Ng DK. Insurance Network Status and 1‐Year Health Care Utilization and Outpatient Costs Among Commercially Insured Patients With Newly Diagnosed and Non‐Definitively Treated Prostate Cancer, 2010–2021. Cancer Medicine. 2026;15(5). doi:10.1002/cam4.71983

BibTeX
@article{Grutman2026,
  author = {Grutman, Aurora J and Alshak, Mark N and Higgins, Michelle I and Pavlovich, Christian P and Ng, Derek K},
  title = {Insurance Network Status and 1‐Year Health Care Utilization and Outpatient Costs Among Commercially Insured Patients With Newly Diagnosed and Non‐Definitively Treated Prostate Cancer, 2010–2021},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {5},
  doi = {10.1002/cam4.71983}
}
Kostenlos starten →